Table 3:
Changes in primary and secondary outcomes among Latina Emergency Medicaid enrollees with gestational diabetes following the expansion of postpartum coverage, 2016-2019, N = 1,670
| Treatment | Comparison | Difference-in- Difference Estimate | |||
|---|---|---|---|---|---|
| (Oregon) | (South Carolina) | ||||
| Pre- Policy | Post- Policy | Pre- Policy | Post- Policy | Adjusted Difference | |
| N = 824 No. (%) | N = 519 No. (%) | N = 223 No. (%) | N = 104 No. (%) | % (95% CI) | |
| Primary Outcomes | |||||
| GTT/Blood Sugar Testing | 30 (3.6) | 141 (27.2) | 5 (2.2) | 1 (1.0) | 25.4 (18.7 - 32.2) | 
| Type 2 Diabetes Mellitus Diagnosis | 3 (0.4) | 24 (4.6) | 2 (0.9) | 0 (0.0) | 5.4 (3.1 - 7.7) | 
| Secondary Outcomes | |||||
| Postpartum Visit Attendance | 70 (8.5) | 318 (61.3) | 40 (17.9) | 20 (19.2) | 52.0 (39.4 - 64.5) | 
| Postpartum Contraception | 98 (11.9) | 242 (46.6) | 9 (4.0) | 4 (3.8) | 35.6 (26.1 - 45.0) | 
| Hospital Readmission | 7 (0.8) | 17 (3.3) | 2 (0.9) | 0 (0.0) | 3.2 (0.8 - 5.5) |